Anticancer: Cisplatin/carboplatin

This publication has 54 references indexed in Scilit:

• Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II)
  Biochemistry, 1993
• Is Cisplatin a Human Carcinogen?
  JNCI Journal of the National Cancer Institute, 1992
• Partial reversibility of cisplatin nephrotoxicity in children
  The Journal of Pediatrics, 1991
• Cisplatin nephrotoxicity: insights into mechanism
  International Journal of Andrology, 1987
• Aortic pressure as a determinant of cardiac protein degradation
  American Journal of Physiology-Cell Physiology, 1986
• Uptake and metabolism of cisplatin by rat kidney
  Kidney International, 1984
• Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin
  Cancer Letters, 1983
• Inhibition of cis-platinum nephrotoxicity by diethyldithiocarbamate rescue in a rat model.
  Proceedings of the National Academy of Sciences, 1979
• CIS-dichlorodiammineplatinum (II)
  Biochemical Pharmacology, 1970
• Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro
  International Journal of Cancer, 1970